Headline News

 

Johnson and Johnson’s RYBREVANT FASPRO earns US FDA Priority Review as a potential first-in-class EGFR and MET-targeted subcutaneous therapy for advanced head and neck cancer

Posted on August 03, 2026

Abbott kicks off a clinical investigation to capture outcomes from real-world use of TriClip in patients with a malfunctioning tricuspid heart valve

Posted on August 03, 2026

Hansoh Pharma reports encouraging outcomes from a second Phase III investigation of Ris-Rez

Posted on August 03, 2026

Lilly’s olomorasib granted US FDA Breakthrough Therapy designation for previously treated KRAS G12C-mutant advanced pancreatic cancer

Posted on August 03, 2026

EC grants approval for AbbVie’s RINVOQ in adults and adolescents with severe alopecia areata

Posted on August 03, 2026

FDA clears Pluvicto for PSMA-positive metastatic hormone-sensitive prostate cancer

Posted on August 03, 2026

Novo Nordisk shares headline results from the ZEUS Phase 3 trial in people with ASCVD, CKD, and inflammation

Posted on August 03, 2026

Datroway cleared in the EU as the only TROP2-directed medicine with an overall survival benefit in first-line treatment of metastatic TNBC patients who are not immunotherapy candidates

Posted on August 03, 2026

Pfizer and BioNTech secures clearance for their XFG-targeted COVID-19 vaccine across EU member states

Posted on August 03, 2026

Pfizer reports positive Phase 3 findings for LITFULO in patients with nonsegmental vitiligo

Posted on August 03, 2026

CHMP issues positive opinion for Gilead’s Trodelvy plus Keytruda in PD-L1-positive first-line metastatic triple-negative breast cancer

Posted on July 27, 2026

Novo Nordisk launches their legal action to halt a series of misleading national GLP-1 advertising campaigns by Eli Lilly

Posted on July 27, 2026

Thermo Fisher Scientific unveils Thermo Scientific InstaFlux to help food microbiology laboratories streamline pathogen and environmental testing workflows

Posted on July 27, 2026

Thermo Fisher Scientific showcases end-to-end diagnostic and laboratory solutions targeting unmet clinical needs at ADLM 2026

Posted on July 27, 2026

CHMP issues positive recommendation for EU approval of Roche’s Susvimo

Posted on July 27, 2026